APOE and Alzheimer disease: The Cogstate Pre-clinical Alzheimer’s Battery – measuring attention, processing speed, visual learning, and working memory – can reliably differentiate between healthy, MCI, and AD populations; with greater decline observed in those who carry the apolipoprotein E gene (APOE) ε4 allele, conferring increased for AD (Lim et al., 2012, 2015).